Ardigen | Top AI-Powered CRO for Drug Discovery & Clinical Trials https://validator.w3.org/feed/docs/rss2.html The AI-Biology Convergence: Designing the Next Generation of Biologics Finding responders with multimodal fusion of histology and clinical data The invisible bridge: How UX design can support AI success in bioinformatics? Real-time analytics for Clinical Trials Multimodal data integration for machine learning project Predicting gene essentiality from omics data Leveraging biomarkers to bring the right treatment to the right patient Latest progress and tools for de novo generation of peptides Antibody Hit Screening: Developing Successful Therapies with the Help of In Silico Tools From bulk to spatial: How transcriptomics is changing the way we see biology Can You Trust Your Model? Why Explainability Matters in AI-Driven Drug Discovery Foundational Models for AI in Biology Uncovering novel targets and approaches to treating neurological diseases Transforming clinical trial reporting: A scalable and compliant data platform The 49% Problem: Why Closing the Lab-AI Loop Starts Beneath the Iceberg The Scaling Paradox: Why Adding More Cloud Resources in Bioinformatics Doesn’t Always Solve the Problem From patient data to novel targets and biomarkers: UK Biobank use What type of data do you need for AI Drug Discovery? AI-Driven De Novo Generation of Protein Binders Unlock biological insights in populational proteomics dataset Unveiling the Parkinson’s Disease microbiome signature Scaling AI in Life Sciences: Why Data Infrastructure Determines Success Large Language Model platform for patient-friendly content What’s trending in European Biopharma? A look ahead Where AI Meets Wet-Lab: A Smarter Path to Biologics Discovery Success The Applications of Morphological Profiling for Drug Discovery: The success stories What 4 Life Sciences Conferences Revealed About AI in Drug Discovery Lab-in-the-Loop: reclaiming the 50% of scientific time lost to data Knowledge Graphs in Drug Discovery: Bringing Context to Internal Data Assets How BBB-Penetrating Antibodies Cross the Blood-Brain Barrier Computer Vision Meets Life Sciences: Inside the CVPR 2025 Workshop Co-Organized by Ardigen Ardigen co-organizes CVPR 2025 workshop on Computer Vision for Drug Discovery Ardigen: Discover One-Week Transition to Cloud Infrastructure for Biotech Companies One-Week Transition to Cloud Infrastructure for Biotech Companies Homepage Where Biology Meets Data: Key Takeaways from Festival of Biologics & BioTechX 2025 AI CROs and the Pharma Shift: The Next Wave of Drug Discovery Innovation The Future of Drug Discovery: Integrating Phenotypic Data with Omics and AI Target Identification: The Cornerstone of the Drug Discovery Process Target Identification: From Poor Data to Quality Predictions Recent Successes in Phenotypic Drug Discovery and the Future of ML/AI Methods Precision Trials: Using AI to Identify Responders Piotr Faba End to End Data-to-Decision Journey for AI-Driven Phenomics in Drug Discovery Optimizing Bioinformatics Workflows: Why it matters and when to start thinking about it? Michał Warchoł Magdalena Otrocka Maciej Jasiński Knowledge Graphs Knowledge hub